{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:20:19Z","timestamp":1648858819893},"reference-count":216,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1971,12,1]],"date-time":"1971-12-01T00:00:00Z","timestamp":60393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pneumologie"],"published-print":{"date-parts":[[1971,12]]},"DOI":"10.1007\/bf02095045","type":"journal-article","created":{"date-parts":[[2005,9,12]],"date-time":"2005-09-12T13:32:58Z","timestamp":1126531978000},"page":"305-323","source":"Crossref","is-referenced-by-count":0,"title":["Bilanz der Chemotherapie der Tuberkulose"],"prefix":"10.1007","volume":"145","author":[{"given":"E.","family":"Jancik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02095045_CR1","first-page":"320","volume":"98","author":"American Thoracic Society","year":"1968","unstructured":"American Thoracic Society: Ethambutol in the treatment of tuberculosis. A statement by the Committee on Therapy. Amer. Rev. resp. Dis.98, 320\u2013321 (1968 a).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR2","first-page":"484","volume":"97","author":"American Thoracic Society","year":"1968","unstructured":"\u2014\u2014 Adrenal corticosteroids and tuberculosis. A statement by the Committee on Therapy. Amer. Rev. resp. Dis.97, 484\u2013485 (1968 b).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR3","first-page":"479","volume":"97","author":"American Thoracic Society","year":"1968","unstructured":"\u2014\u2014 Therapy of pleural effusion. A statement by the Committee on Therapy. Amer. Rev. resp. Dis.97, 479\u2013483 (1968 c).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR4","first-page":"969","volume":"99","author":"American Thoracic Society","year":"1969","unstructured":"\u2014\u2014 Abstracts of papers presented at the Annual Meeting of the ATS held in conjunction with the Meetings of the National Tuberculosis and Respiratory Disease Association and the National Respiratory Disease Conference, May 24\u201326, 1969. Amer. Rev. resp. Dis.99, 969\u2013971 (1969 a).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR5","first-page":"257","volume":"100","author":"American Thoracic Society","year":"1969","unstructured":"\u2014\u2014 A statement by the Committee on Therapy: Intermittent chemotherapy for tuberculosis. Amer. Rev. resp. Dis.100, 257\u2013259 (1969 b).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0041-3879(69)90054-3","volume":"50","author":"J. C. Batten","year":"1969","unstructured":"Batten, J. C.: Rifampicin in treatment of experimental tuberculosis in mice. Tubercle (Lond.)50, 294\u2013298 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0041-3879(70)90132-7","volume":"51","author":"J. C. Batten","year":"1970","unstructured":"\u2014\u2014 Rifampicin in the treatment of experimental tuberculosis in mice: Sterilization of tubercle bacilli in the tissues. Tubercle (Lond.)51, 95\u201399 (1970).","journal-title":"Tubercle"},{"key":"BF02095045_CR8","first-page":"897","volume":"36","author":"E. Bek","year":"1968","unstructured":"Bek, E., Bukalska, Z., Stachlewska, S. Zachara, A.: Criteria of inactivity in pulmonary tuberculosis with correct chemotherapy. Gru\u017alica36, 897\u2013901 (1968).","journal-title":"Gru\u017alica"},{"key":"BF02095045_CR9","first-page":"183","volume":"41","author":"E. Bernard","year":"1968","unstructured":"Bernard, E.: Traitement des tuberculoses pulmonaires inv\u00e9t\u00e9r\u00e9es (hyperchroniques) \u00e0 bacilles r\u00e9sistants, par la polychimioth\u00e9rapie antibacillaire. Bull. Un. int. Tuberc.41, 183\u2013185 (1968).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR10","first-page":"5","volume":"74","author":"N. Bethlem","year":"1968","unstructured":"Bethlem, N., Mendes, W.: Blind treatment of tuberculosis with second-line drugs. Hospital (Rio)74, 5 (1968).","journal-title":"Hospital"},{"key":"BF02095045_CR11","first-page":"7","volume":"42","author":"J. R. Bignall","year":"1969","unstructured":"Bignall, J. R., Lind, A., et Coll.: Comparaison des r\u00e9gimes d'\u00e9thionamide, de pyrazinamide et de cyclos\u00e9rine dans le traitement de malades atteints de tuberculose pulmonaire et d\u00e9j\u00e0 trait\u00e9s ant\u00e9rieurement. Bull. Un. int. Tuberc.42, 7\u201364 (1969).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR12","first-page":"471","volume":"60","author":"M. B\u00f6sz\u00f6rm\u00e9nyi","year":"1969","unstructured":"B\u00f6sz\u00f6rm\u00e9nyi, M., Fauszt, I., K\u00e1rolyi, A., Seri, I., V\u00e1mos, K.: Nos premi\u00e8res exp\u00e9riences cliniques sur la rifampicine. Acta tuberc. pneumol. belg.60, 471\u2013477 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR13","first-page":"217","volume":"II","author":"British Medical Research Council","year":"1953","unstructured":"British Medical Research Council: Emergence of bacterial resistance in pulmonary tuberculosis under treatment with isoniazid, streptomycin plus PAS, streptomycin plus PAS and streptomycin plus isoniazid. Lancet1953 aII, 217\u2013223.","journal-title":"Lancet"},{"key":"BF02095045_CR14","first-page":"213","volume":"II","author":"British Medical Research Council","year":"1953","unstructured":"\u2014\u2014 Laboratory techniques for the determination of sensitivity of bacilli to isoniazid, streptomycin and PAS. Lancet1953 bII, 213\u2013217.","journal-title":"Lancet"},{"key":"BF02095045_CR15","first-page":"521","volume":"I","author":"British Medical Research Council","year":"1953","unstructured":"\u2014\u2014 Isoniazid in the treatment of pulmonary tuberculosis. Brit. med. J.1953 cI, 521\u2013536.","journal-title":"Brit. med. J."},{"key":"BF02095045_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0041-3879(62)80066-X","volume":"43","author":"British Medical Research Council","year":"1962","unstructured":"\u2014\u2014 Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation. Tubercle (Lond.)43, 201\u2013368 (1962).","journal-title":"Tubercle"},{"key":"BF02095045_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0041-3879(61)80130-X","volume":"42","author":"British Tuberculosis Association","year":"1961","unstructured":"British Tuberculosis Association: A trial of corticotrophin and prednisone with chemotherapy in pulmonary tuberculosis. Tubercle (Lond.)42, 391\u2013412 (1961).","journal-title":"Tubercle"},{"key":"BF02095045_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0041-3879(68)90017-2","volume":"49","author":"British Tuberculosis Association","year":"1968","unstructured":"\u2014\u2014 A comparison of the toxicity of prothionamide and ethionamide. Tubercle (Lond.)49, 125\u2013135 (1968).","journal-title":"Tubercle"},{"key":"BF02095045_CR19","first-page":"173","volume":"33","author":"H. Brocard","year":"1969","unstructured":"Brocard, H., Akoun, G., Depierre, A., Muon, N., Tob\u00e9, F. M.: La rifampicine dans le traitement de la tuberculose pulmonaire. A propos de 40 observations. Rev. Tuberc. (Paris)33, 173\u2013176 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR20","first-page":"263","volume":"2","author":"G. Brouet","year":"1970","unstructured":"Brouet, G.: Action th\u00e9rapeutique des nouveaux antibiotiques. Crit\u00e8res d'activit\u00e9. Seizi\u00e8me Congr\u00e8s National de la Tuberculose et des Maladies Respiratoires, Bordeaux, 2, 3 et 4 Avril 1970, pp. 263, pp. 163\u2013200. Paris: Masson et Cie 1970.","journal-title":"Bordeaux"},{"key":"BF02095045_CR21","first-page":"228","volume":"28","author":"G. Brouet","year":"1958","unstructured":"\u2014\u2014 Marche, J., Rist, N., Chevalier, J., Le Meur, G.: Thioamide de l'acide alpha-\u00e9thylisonicotinique (1314 TH). \u00c9tude clinique. Bull. Un. int. Tuberc.28, 228\u2013240 (1958).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR22","first-page":"121","volume":"33","author":"G. Brouet","year":"1969","unstructured":"\u2014\u2014 Modai, J., Vergez, P.: Essais cliniques de la rifampicine en monoth\u00e9rapie. Rev. Tuberc. (Paris)33, 121\u2013132 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR23","first-page":"28","volume":"101","author":"G. Canetti","year":"1961","unstructured":"Canetti, G., Grosset, J.: Teneur des souches sauvages de Mycobacterium tuberculosis en variants r\u00e9sistants \u00e0 l'isoniazide et en variants \u00e0 la streptomycine sur milieu de Loewenstein-Jensen. Ann. Inst. Pasteur101, 28\u201346 (1961).","journal-title":"Ann. Inst. Pasteur"},{"key":"BF02095045_CR24","first-page":"217","volume":"27","author":"G. Canetti","year":"1963","unstructured":"\u2014\u2014 \u2014\u2014 M\u00e9sure de la sensibilit\u00e9 du bacille tuberculeux aux drogues antibacillaires par la m\u00e9thode des proportions. Rev. Tuberc. (Paris)27, 217\u2013272 (1963).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0041-3879(63)80118-X","volume":"44","author":"G. Canetti","year":"1963","unstructured":"\u2014\u2014 Grumbach, F., Grosset, J.: Long-term two stage chemotherapy of advanced experimental murine tuberculosis with intermittent regimes during the second stage. Tubercle (Lond.)44, 236\u2013240 (1963).","journal-title":"Tubercle"},{"key":"BF02095045_CR26","first-page":"91","volume":"33","author":"G. Canetti","year":"1969","unstructured":"\u2014\u2014 Le Lirzin, M., Porven, G.: Comparaison entre la rifampicine et l'isoniazide. Dilutions inhibitrices minimales du s\u00e9rum de l'homme aux doses th\u00e9rapeutiques habituelles. Rev. Tuberc. (Paris)33, 91\u201394 (1969 a).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0041-3879(68)80017-0","volume":"49","author":"G. Canetti","year":"1968","unstructured":"\u2014\u2014 \u2014\u2014 \u2014\u2014 Le Lirzin, M. Proven, G. Rist, N., Grumbach, F.: Some Comparative Aspects of Rifampicin and Isoniazid. Tubercle (Lond.)49, 367\u2013376 (1968).","journal-title":"Tubercle"},{"key":"BF02095045_CR28","first-page":"315","volume":"60","author":"G. Canetti","year":"1969","unstructured":"\u2014\u2014 Parrot, R., Porven, G., Le Lirzin, M.: Les taux de rifampicine dans le poumon et dans les l\u00e9sions tuberculeuses de l'homme. Rev. tuberc. pneumol. belg.60, 315\u2013322 (1969 b).","journal-title":"Rev. tuberc. pneumol. belg."},{"key":"BF02095045_CR29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0041-3879(67)80007-2","volume":"48","author":"P. Chaulet","year":"1967","unstructured":"Chaulet, P., Larbaoui, D., Grosset, G., Abderrahim, K.: Intermittent Chemotherapy with Isoniazid and Streptomycin in Algiers. Tubercle (Lond.)48, 128\u2013136 (1967).","journal-title":"Tubercle"},{"key":"BF02095045_CR30","first-page":"1182","volume":"98","author":"O. T. Cheung","year":"1968","unstructured":"Cheung, O. T., Pugsley, H. E.: A Follow-Up Study of 134 Cases of Pulmonary Tuberculosis Treated with Adequate Chemotherapy in 1953\u20131954. Canad. Med. Ass. J.98, 1182\u20131183 (1968).","journal-title":"Canad. Med. Ass. J."},{"key":"BF02095045_CR31","first-page":"731","volume":"39","author":"F. J. Chicou","year":"1968","unstructured":"Chicou, F. J., H\u00e9trick, G., Huet, M., Radenac, H., Rist, N.: Comparison of two regimens of oral treatment of pulmonary tuberculosis (ethionamid plus isoniazid, thioacetazone plus isoniazid). Bull. W.H.O.39, 731\u2013769 (1968).","journal-title":"Bull. W.H.O."},{"key":"BF02095045_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0041-3879(69)90079-8","volume":"50","author":"K. M. Citron","year":"1969","unstructured":"Citron, K. M., May, J. R.: The rifampicin in purulent bronchitis. Tubercle (Lond.)50, 329 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR33","first-page":"147","volume":"33","author":"P. Constans","year":"1969","unstructured":"Constans, P., Morin, Y., Saint-Paul, M., Bonnaud, G., Coury, C., Bari\u00e9ty, M.: L'association rifampicine-isoniazide. R\u00e9sultats bact\u00e9riologiques et radiocliniques du traitement de 56 tuberculoses pulmonaires r\u00e9centes. Rev. Tuberc. (Paris)33, 147\u2013154 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR34","first-page":"299","volume":"60","author":"P. Constans","year":"1969","unstructured":"\u2014\u2014 Saint-Paul, M., Morin, Y., Bonnaud, G., Bari\u00e9ty, M.: Etude des taux plasmatiques de rifampicine et de leurs variations (440 dosages). Rev. tuberc. pneumol. belg.60, 299\u2013314 (1969).","journal-title":"Rev. tuberc. pneumol. belg."},{"key":"BF02095045_CR35","first-page":"949","volume":"97","author":"R. F. Corpe","year":"1968","unstructured":"Corpe, R. F., Blalock, F. A., In: The twenty-seventh Veterans Administration-Armed Forces Pulmonary Disease Research Conference (Report by E. Rothstein). Amer. Rev. resp. Dis.97, 949 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR36","first-page":"954","volume":"98","author":"R. F. Corpe","year":"1968","unstructured":"\u2014\u2014 \u2014\u2014 A continuing study of patients with \u201eOpen-Negative\u201c status at Battey State Hospital. Amer. Rev. resp. Dis.98, 954\u2013964 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR37","first-page":"213","volume":"27","author":"J. Crofton","year":"1957","unstructured":"Crofton, J., In: La signification clinique des mesures de r\u00e9sistance bact\u00e9rienne. Bull. Un. int. Tuberc.27, 213\u2013279 (1957).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR38","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/bmj.1.5138.1610","volume":"1","author":"J. Crofton","year":"1959","unstructured":"\u2014\u2014 Chemotherapy of pulmonary tuberculosis. Brit. med. J.1, 1610 (1959).","journal-title":"Brit. med. J."},{"key":"BF02095045_CR39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0041-3879(69)90009-9","volume":"50","author":"J. Crofton","year":"1969","unstructured":"\u2014\u2014 Treatment of patients with drug-resistance in economically developped countries. Tubercle (Lond.) Suppl.50, 65\u201368 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR40","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJM196812052792305","volume":"279","author":"F. J. Curry","year":"1968","unstructured":"Curry, F. J.: Neighborhood clinics for more effective outpatient treatment of tuberculosis. New Engl. J. Med.279, 1262\u20131267 (1968).","journal-title":"New Engl. J. Med."},{"key":"BF02095045_CR41","unstructured":"Daddi, G., Cornia, G., Grassi, C., Perna, G., Scarpazza, G.: Prime osservazioni sull attivit\u00e0 della rifampicina per via orale nella tubercolosi polmonare cronica. Atti del XVIII Congresso Italiano di Tisiologia, Milano, 4-5-6-novembre 1966, vol. 2, pp. 531\u2013532."},{"key":"BF02095045_CR42","first-page":"35","volume":"29","author":"G. Daddi","year":"1969","unstructured":"\u2014\u2014 Lucchesi, M., Mancini, P.: La rifampicina nel trattamento intermittente della tubercolosi sperimentale della cavia. Ann. Ist. C. Forlanini29, 35\u201340 (1969).","journal-title":"Ann. Ist. C. Forlanini"},{"key":"BF02095045_CR43","first-page":"17","volume":"29","author":"G. Daddi","year":"1969","unstructured":"\u2014\u2014 \u2014\u2014 \u2014\u2014 Matzeu, M., Rossi, P.: La rifampicina-sensibilit\u00e0 dei micobatteri. Ann. Ist. C. Forlanini29, 17\u201328 (1969).","journal-title":"Ann. Ist. C. Forlanini"},{"key":"BF02095045_CR44","first-page":"29","volume":"29","author":"G. Daddi","year":"1969","unstructured":"\u2014\u2014 \u2014\u2014 \u2014\u2014 Termine, A.: La virulenza dei ceppi di mycobacterium tuberculosis resistenti alla rifampicina. Ann. Ist. C. Forlanini29, 29\u201333 (1969).","journal-title":"Ann. Ist. C. Forlanini"},{"key":"BF02095045_CR45","first-page":"3","volume":"29","author":"G. Daddi","year":"1969","unstructured":"\u2014\u2014 \u2014\u2014 Rossi, P., Sbampato, M.: La rifampicina nel trattamento della tubercolosi polmonare. Ann. Ist. C. Forlanini29, 3\u201316 (1969).","journal-title":"Ann. Ist. C. Forlanini"},{"key":"BF02095045_CR46","first-page":"155","volume":"33","author":"A. Delaude","year":"1969","unstructured":"Delaude, A., Monnier, J., Albar\u00e8de, J. L., Bourse, R., Puel, J. Mme: La rifampicine dans le traitement de la tuberculose pulmonaire (Premiers r\u00e9sultats). Rev. Tuberc. (Paris)33, 155\u2013162 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR47","first-page":"501","volume":"60","author":"G. E. Destexhe","year":"1969","unstructured":"Destexhe, G. E.: Reprise du traitement par la rifampicine de cas r\u00e9sistants de tuberculose pulmonaire. Acta tuberc. pneumol. belg.60, 501\u2013506 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0041-3879(70)90018-8","volume":"51","author":"S. Devadatta","year":"1970","unstructured":"Devadatta, S., Menon, N. K., Nazareth, O., Dahakrishna, S., Ramakrishnan, C. V., Somasundaram, P. R., Usha, S. P., Velu, S.: A doubleblind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis. Tubercle (Lond.)51, 263\u2013269 (1970).","journal-title":"Tubercle"},{"key":"BF02095045_CR49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0041-3879(68)80016-9","volume":"49","author":"J. M. Dickinson","year":"1968","unstructured":"Dickinson, J. M., Ellard, G. A., Mitchison, D. A.: Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis. Tubercle (Lond.)49, 351\u2013366 (1968).","journal-title":"Tubercle"},{"key":"BF02095045_CR50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0041-3879(69)90075-0","volume":"50","author":"J. M. Dickinson","year":"1969","unstructured":"\u2014\u2014 Mitchison, D. A.: In vitro and animal experiments with rifampicin. Tubercle (Lond.)50, 327 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0041-3879(70)90131-5","volume":"51","author":"J. M. Dickinson","year":"1970","unstructured":"\u2014\u2014 \u2014\u2014 Suitability of rifampicin for intermittent administration in the treatment of tuberculosis. Tubercle (Lond.)51, 82\u201394 (1970).","journal-title":"Tubercle"},{"key":"BF02095045_CR52","first-page":"73","volume":"31","author":"E. Dissmann","year":"1961","unstructured":"Dissmann, E.: La culture sur lames \u2014 m\u00e9thode rapide de mesure de la r\u00e9sistance du bacille tuberculeux aux m\u00e9dicaments. Bull. Un. int. Tuberc.31, 73\u201387 (1961).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1378\/chest.52.1.21","volume":"52","author":"J. Y. Doust","year":"1967","unstructured":"Doust, J. Y., Moatamed, F.: Retreatment program in pulmonary tuberculosis with resistant mycobacteria in South of Iran. Dis. Chest52, 21\u201323 (1967).","journal-title":"Dis. Chest"},{"key":"BF02095045_CR54","first-page":"894","volume":"32","author":"C. Durante","year":"1968","unstructured":"Durante, C., Burzoni, F. J.-M.: Results of a study of the treatment of pulmonary tuberculosis with combined isoniazid and thiacetazone in the province of Marrakech (Morocco). Rev. Tuberc. (Paris)32, 894\u2013859 (1968).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0041-3879(70)90067-X","volume":"51","author":"East African\/British Medical Research Council Fifth Thiazetazone Investigation","year":"1970","unstructured":"East African\/British Medical Research Council Fifth Thiazetazone Investigation: Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East-Africa-Fifth Investigation. Tubercle (Lond.)51, 123\u2013151 (1970).","journal-title":"Tubercle"},{"key":"BF02095045_CR56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0041-3879(69)90049-X","volume":"50","author":"East African\/British Medical Research Council's Investigation","year":"1969","unstructured":"East African\/British Medical Research Council's Investigation: The results from twelve to thirty-six months in patients submitted to two studies of primary chemotherapy for pulmonary tuberculosis in East Africa. Tubercle (Lond.)50, 233\u2013256 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(70)90124-8","volume":"51","author":"East African\/British Medical Research Council Kenya Tuberculosis Survey Follow-up","year":"1970","unstructured":"East African\/British Medical Research Council Kenya Tuberculosis Survey Follow-up: Tuberculosis in Kenya: a follow-up of a national sampling survey of drug resistance and other factors. Tubercle (Lond.)51, 1\u201323 (1970).","journal-title":"Tubercle"},{"key":"BF02095045_CR58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0041-3879(69)90017-8","volume":"50","author":"East African\/British Medical Research Council Pyrazinamide Investigation","year":"1969","unstructured":"East African\/British Medical Research Council Pyrazinamide Investigation: A controlled comparison of four regimes of streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis. Tubercle (Lond.)50, 81\u2013114 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0041-3879(69)90052-X","volume":"50","author":"P. A. Emerson","year":"1969","unstructured":"Emerson, P. A., Lacey, R. W., Breach, M. R.: A bacteriological study of thiocarlide monotherapy. Tubercle (Lond.)50, 273\u2013279 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR60","first-page":"307","volume":"33","author":"J. Espi\u00e9","year":"1969","unstructured":"Espi\u00e9, J.: Pr\u00e9sentation des r\u00e9sultats obtenus lors du traitement de 423 tuberculeux pulmonaires par la rifampicine. Rev. Tuberc. (Paris)33, 307\u2013314 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR61","first-page":"199","volume":"33","author":"G. Favez","year":"1969","unstructured":"Favez, G., Willa, Cl.: Observations pr\u00e9liminaires sur l'emploi de la rifampicine dans le traitement de la tuberculose pulmonaire. Rev. Tuberc. (Paris)33, 199\u2013206 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR62","first-page":"392","volume":"97","author":"D.-A. Fischer","year":"1968","unstructured":"Fischer, D.-A., Lester, W., Dye, W. E., Moulding, Th. S.: Re-treatment with isoniazid-resistant tuberculosis. Amer. Rev. resp. Dis.97, 392\u2013398 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR63","first-page":"29","volume":"98","author":"D.-A. Fischer","year":"1968","unstructured":"\u2014\u2014 \u2014\u2014 Schaeffer, W. B.: Infections with atypical mycobacteria. Five year's experience at the National Jewish Hospital. Amer. Rev. resp. Dis.98, 29\u201334 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0041-3879(69)90033-6","volume":"50","author":"F. P. Figueiredo de","year":"1969","unstructured":"Figueiredo, F. P. de: Treatment of patients with pulmonary tuberculosis classified according to the history of previous chemotherapy and without reference to pretreatment drug sensitivity. Tubercle (Lond.)50, 335\u2013343 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR65","first-page":"767","volume":"97","author":"W. Fox","year":"1968","unstructured":"Fox, W.: The John Barnwell lecture \u2014 Changing concepts in the chemotherapy of pulmonary tuberculosis. Amer. Rev. resp. Dis.97, 767\u2013790 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR66","first-page":"55","volume":"50","author":"W. Fox","year":"1969","unstructured":"\u2014\u2014 Problems of treatment of drug resistance in the developping countries. Tubercle (Lond.)50, 55\u201365 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0041-3879(69)90019-1","volume":"50","author":"W. Fox","year":"1969","unstructured":"\u2014\u2014 Robinson, D. K., Tall, R., Mitchison, D. A., Kent, P. W., Macfadyen, D. N.: A study of acute intolerance to ethionamide, including a comparison with prothionamide, and the influence of a vitamin B-complex additive in prophylaxis. Tubercle (Lond.)50, 125\u2013143 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR68","first-page":"251","volume":"60","author":"E. Freerksen","year":"1969","unstructured":"Freerksen, E.: Introductive remarks on rifampicin. Acta tub. pneumol. belg.60, 251\u2013253 (1969).","journal-title":"Acta tub. pneumol. belg."},{"key":"BF02095045_CR69","first-page":"139","volume":"95","author":"E. Freerksen","year":"1970","unstructured":"\u2014\u2014 Fortschritte in der Tuberkulose-Behandlung. Isoniazid + Rifampicin + Myambutol als neue \u201cStandardtherapie\u201d. Dtsch. med. Wschr.95, 139\u2013141 (1970).","journal-title":"Dtsch. med. Wschr."},{"key":"BF02095045_CR70","unstructured":"Freerksen, E., Orlowski, E.-H.: Tuberkulose 1970 \u2014 Eine Zwischenbilanz. Deutsche Rentenversicherung, pp. 261\u2013267 (1970)."},{"key":"BF02095045_CR71","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02136755","volume":"141","author":"E. Freerksen","year":"1970","unstructured":"\u2014\u2014 Rosenfeld, M., Orlowski, E.-H.: Isoniazid + Rifampicin + Myambutol, eine neue Standard-kombination f\u00fcr die medikament\u00f6se Behandlung der Tuberkulose. Beitr. Klin. Tuberk.141, 273\u2013296 (1970).","journal-title":"Beitr. Klin. Tuberk."},{"key":"BF02095045_CR72","first-page":"451","volume":"36","author":"S. Frenkel","year":"1968","unstructured":"Frenkel, S., W\u00f3jcik, B., Jaworski, J.: The fate of tuberculous patients with the \u201copen-negative\u201d syndrome. Gru\u017alica36, 451\u2013454 (1968).","journal-title":"Gru\u017alica"},{"key":"BF02095045_CR73","first-page":"53","volume":"5","author":"C. Gernez-Rieux","year":"1960","unstructured":"Gernez-Rieux, C., Tacquet, A., Fournier, P., Macquet, V.: Notre exp\u00e9rience du 1314 Th (Tr\u00e9cator) dans le traitement de la tuberculose pulmonaire. Lille m\u00e9d.5, 53\u201360 (1960).","journal-title":"Lille m\u00e9d."},{"key":"BF02095045_CR74","first-page":"263","volume":"2","author":"C. Gernez-Rieux","year":"1970","unstructured":"\u2014\u2014 \u2014\u2014 Devulder, B., Debruyne, J.: Les mycobact\u00e9rioses humaines. M\u00e9thodes actuelles de diagnostic bact\u00e9riologique. Aspects cliniques, th\u00e9rapeutiques et \u00e9pid\u00e9miologiques. Seizi\u00e8me Congr\u00e8s National de la Tuberculose et des Maladies Respiratoires, Bordeaux, 2, 3 et 4 Avril 1970, p. 263, pp. 1\u201370. Paris: Masson et Cie 1970.","journal-title":"Bordeaux"},{"key":"BF02095045_CR75","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/thx.23.1.94","volume":"23","author":"K. P. Goldman","year":"1968","unstructured":"Goldman, K. P.: Treatment of unclassified mycobacterial infection of the lungs. Thorax (Lond.)23, 94\u201399 (1968).","journal-title":"Thorax"},{"key":"BF02095045_CR76","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0041-3879(68)80024-8","volume":"49","author":"M. Govindaraj","year":"1968","unstructured":"Govindaraj, M.: Multiple-drug reactions in tuberculosis \u2014 an illustrative case. Tubercle (Lond.)49, 416\u2013418 (1968).","journal-title":"Tubercle"},{"key":"BF02095045_CR77","first-page":"225","volume":"33","author":"C. Grassi","year":"1969","unstructured":"Grassi, C. (avec la collaboration d'autres): Traitement des cas de tuberculose chronique avec \u00e9thambutol et prothionamide associ\u00e9s \u00e0 rifampicine ou capr\u00e9omycine. Rev. Tuberc. (Paris)33, 225\u2013230 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR78","first-page":"53","volume":"33","author":"F. Grumbach","year":"1969","unstructured":"Grumbach, F.: Comparaison entre la rifampicine et l'isoniazide \u2014 Activit\u00e9 exp\u00e9rimentale chez la souris. Rev. Tuberc. (Paris).33, 53\u201358 (1969 a).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0041-3879(69)90053-1","volume":"50","author":"F. Grumbach","year":"1969","unstructured":"\u2014\u2014 Experimental (in vivo) studies of new antituberculous drugs: capreomycin, ethambutol, rifampicin. Tubercle (Lond.) Suppl.50, 12\u201321 (1969 b).","journal-title":"Tubercle"},{"key":"BF02095045_CR80","first-page":"390","volume":"60","author":"F. Grumbach","year":"1970","unstructured":"\u2014\u2014 La rifampicine dans les traitements associ\u00e9s, continus et intermittents de la tuberculose exp\u00e9rimentale de la souris. Acta tuberc. pneumol. belg.60, 390\u2013396 (1970).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0041-3879(69)90053-1","volume":"50","author":"F. Grumbach","year":"1969","unstructured":"\u2014\u2014 Canetti, G., Le Lirzin, M.: Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results. Tubercle (Lond.)50, 280\u2013293 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR82","first-page":"749","volume":"31","author":"F. Grumbach","year":"1967","unstructured":"\u2014\u2014 Rist, N.: Activit\u00e9 antituberculeuse exp\u00e9rimentale de la rifampicine, d\u00e9riv\u00e9 de la rifamycine SV. Rev. Tuberc. (Paris)31, 749 (1967).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0041-3879(69)90078-6","volume":"50","author":"A. Gyselen","year":"1969","unstructured":"Gyselen, A., Simon-Pouthier, F.: Clinical results in first treatment and retreatment of advanced pulmonary tuberculosis with rifampicin. Tubercle (Lond.)50, 328\u2013329 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR84","first-page":"563","volume":"60","author":"A. Gyselen","year":"1969","unstructured":"\u2014\u2014 Verbist, L., Cosemans, J., Lacquet, L. M., Prignot, J., Simon-Pouthier, F., Brabandere, R. de, Devriendt, J.: A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis. Acta tuberc. pneumol. belg.60, 563\u2013576 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR85","first-page":"933","volume":"68","author":"A. Gyselen","year":"1968","unstructured":"\u2014\u2014 \u2014\u2014 \u2014\u2014 \u2014\u2014 Vandenbergh, E.: Rifampicin and ethambutol in the retreatment of advanced pulmonary tuberculosis. Amer. Rev. resp. Dis.68, 933\u2013943 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR86","first-page":"133","volume":"33","author":"A. Gyselen","year":"1969","unstructured":"\u2014\u2014 \u2014\u2014 Simon-Pouthier, F., Prignot, J., Brabandere, R. de: La rifampicine dans le traitement d'attaque de la tuberculose pulmonaires (R\u00e9sultats pr\u00e9liminaires d'une \u00e9tude comparative). Rev. Tuberc. (Paris),33, 133\u2013134 (1969).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR87","first-page":"406","volume-title":"Antibiotica et Chemotherapia, vol. 16","author":"A. Havel","year":"1970","unstructured":"Havel, A., Ad\u00e1mak, L., \u0160imonov\u00e1, S.: Rifampicin in experimental investigations on mice. Antibiotica et Chemotherapia, vol. 16, pp. 406\u2013415. Basel-M\u00fcnchen-New York: Karger 1970."},{"key":"BF02095045_CR88","first-page":"17","volume-title":"Antibiotica et Chemotherapia, vol. 16","author":"A. Havel","year":"1970","unstructured":"\u2014\u2014 \u2014\u2014 The effect of capreomycin on \u201catypical\u201d and avian mycobacterial strains in vitro. Antibiotica et Chemotherapia, vol. 16, pp. 17\u201319. Basel-M\u00fcnchen-New York: Karger 1970."},{"key":"BF02095045_CR89","first-page":"42","volume":"72","author":"O. Heinivaara","year":"1970","unstructured":"Heinivaara, O., Lindeberg, L., P\u00e4ti\u00e4l\u00e4, J.: The frequency of postpleuritic tuberculosis. Scand. J. resp. Dis. Suppl.72, 42\u201344 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR90","first-page":"5","volume":"31","author":"P. Hertzog","year":"1967","unstructured":"Hertzog, P., Toty, L., Personne, C., Chevassu, J.: Homolateral relapse after upper, segmental or lobar resections for tuberculosis: A clinical follow-up study. Rev. Tuberc. (Paris)31, 5\u201316 (1967).","journal-title":"Rev. Tuberc."},{"key":"BF02095045_CR91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0041-3879(70)90029-2","volume":"51","author":"J. P. Hollins","year":"1970","unstructured":"Hollins, J. P., Simmons, A. V.: Jaundice associated with rifampicin. Tubercle (Lond.)51, 328\u2013332 (1970).","journal-title":"Tubercle"},{"key":"BF02095045_CR92","first-page":"2","volume":"50","author":"N. W. Horne","year":"1969","unstructured":"Horne, N. W.: Drug-resistant tuberculosis: a review of the world situation. Tubercle (Lond.) Suppl.50, 2\u201312 (1969).","journal-title":"Tubercle"},{"key":"BF02095045_CR93","first-page":"183","volume":"99","author":"O. Horwitz","year":"1969","unstructured":"Horwitz, O.: Public health aspects of relapsing tuberculosis. Amer. Rev. resp. Dis.99, 183\u2013193 (1969).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR94","first-page":"11","volume":"74","author":"I. H\u00f8yer","year":"1970","unstructured":"H\u00f8yer, I.: Prognosis of pulmonary tuberculosis in diabetes before and after induction of chemotherapy. Scand. J. resp. Dis. Suppl.74 11 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR95","first-page":"12","volume":"38","author":"I. Hut\u00e1s","year":"1960","unstructured":"Hut\u00e1s, I., Nyiredy, G.: Comparative function studies in cases of exsudative pleurisy treated with and without corticosteroids. Acta tuberc. scand.38 12\u201317 (1960).","journal-title":"Acta tuberc. scand."},{"key":"BF02095045_CR96","first-page":"4","volume":"31","author":"E. Jan\u010d\u00edk","year":"1961","unstructured":"Jan\u010d\u00edk, E.: The treatment of pulmonary tuberculosis in patients harbouring bacilli resistant to the three major drugs. Symposium held in Paris on September 8, 1960 and presided over by E. Jan\u010dik (Czechoslovakia), Members: N. W. Horne (Great Britain), Prof. B. Kreis (France), Prof. M. Lucchesi (Italy), J. W. Raleigh (U.S.A.) and Prof. M. Zierski (Poland). Bull. int. Tuberc.31 4\u201360 (1961).","journal-title":"Bull. int. Tuberc."},{"key":"BF02095045_CR97","unstructured":"-- Ethionamid treatment in Czechoslovakia: A preliminary report. Trans 21st Res. Conf. pulm. Dis. VA-AF (St. Louis) 311\u2013321 (1962)."},{"key":"BF02095045_CR98","first-page":"100","volume":"33","author":"E. Jan\u010d\u00edk","year":"1963","unstructured":"\u2014\u2014 Etude comparative des r\u00e9sultats obtenus par les associations chimioth\u00e9rapiques majeures chez des malades \u00e0 bacilles de r\u00e9sistance basse et chez des malades \u00e0 bacilles de r\u00e9sistance \u00e9lev\u00e9e, \u00e0 la m\u00eame drogue. Bull. Un. int. Tuberc.33 100\u2013119 (1963).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR99","first-page":"131","volume":"122","author":"E. Jan\u010d\u00edk","year":"1964","unstructured":"\u2014\u2014 Die Behandlung von Lungentuberkulosekranken mit resistenten Tuberkelbazillen. Z. Tuberk.122 131\u2013140 (1964 a).","journal-title":"Z. Tuberk."},{"key":"BF02095045_CR100","first-page":"121","volume":"13","author":"E. Jan\u010d\u00edk","year":"1964","unstructured":"\u2014\u2014 Effects des agents antibacillaires dits secondaires sur la tuberculose pulmonaire. Progr. Explor. Tuberc., vol. 13, pp. 121\u2013218. Basel-M\u00fcnchen-New York: Karger 1964b.","journal-title":"Progr. Explor. Tuberc."},{"key":"BF02095045_CR101","first-page":"165","volume":"35","author":"E. Jan\u010d\u00edk","year":"1964","unstructured":"\u2014\u2014 Meilleurs r\u00e9gimes chimioth\u00e9rapiques chez les malades d\u00e9j\u00e0 trait\u00e9s dont les bacilles sont r\u00e9sistants aux drogues antibacillaires majeures. Bull. Un. int. Tuberc.35 165\u2013170 (1964 c).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR102","first-page":"925","volume":"116","author":"E. Jan\u010d\u00edk","year":"1966","unstructured":"\u2014\u2014 Die Behandlung von Tuberkulosekranken mit resistenten Tuberkelbazillen. Wien. med. Wschr.116 925\u2013929 (1966).","journal-title":"Wien. med. Wschr."},{"key":"BF02095045_CR103","first-page":"105","volume":"65","author":"E. Jan\u010d\u00edk","year":"1968","unstructured":"\u2014\u2014 Methods and fight against chronic tuberculosis in Czechoslovakia. Scand. J. resp. Dis. Suppl.65 105\u2013111 (1968).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR104","first-page":"52","volume":"50","author":"E. Jan\u010d\u00edk","year":"1969","unstructured":"\u2014\u2014 The use of ethambutol in clinical practice. Tubercle (Lond.) Suppl.50 52\u201354 (1969).","journal-title":"Tubercle (Lond.) Suppl."},{"key":"BF02095045_CR105","first-page":"306","volume":"71","author":"E. Jan\u010d\u00edk","year":"1970","unstructured":"\u2014\u2014 Bou\u010dkov\u00e1, I., Jan\u010d\u00edkov\u00e1, M., Nov\u00e1k, M.: Clinical and laboratory experiences with cycloserine. Scand. J. resp. Dis. Suppl.71 306\u2013313 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR106","first-page":"188","volume":"41","author":"E. Jan\u010d\u00edk","year":"1969","unstructured":"\u2014\u2014 Nov\u00e1k, M., Jan\u010dikov\u00e1, M., Tou\u0161ek, J., Kr\u00e1tk\u00fd, J., Feitov\u00e1, S., Zelenka, M.: Quelques aspects concernant de nouvelles associations de drogues dans le traitement de la tuberculose \u00e0 bacilles r\u00e9sistants. Bull. Un. int. Tuberc.41 188\u2013191 (1969).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR107","first-page":"199","volume":"43","author":"Japan","year":"1968","unstructured":"Japan: Cooperative Study Unit on Chemotherapy of Tuberculosis of National Sanatoria in Japan (Chairman S. Sunahara): Comparison of single, double, and triple drug regimens in the re-treatment of drug-resistant pulmonary tuberculosis. Seventh Series of Trial, Part B. Kekkaku43 199\u2013207 (1968).","journal-title":"Seventh Series of Trial, Part B. Kekkaku"},{"key":"BF02095045_CR108","unstructured":"Japan: A Statement by the Tuberculosis Treatment Research Committee. Kekkaku 1970 a."},{"key":"BF02095045_CR109","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0041-3879(70)90019-X","volume":"51","author":"Japan","year":"1970","unstructured":"Japan: Cooperative Study group of the Japanese National Sanatoria on Atypical Mycobacteria: A study on the frequency of \u201catypical\u201d mycobacteria in Japanese National sanatoria. Tubercle (Lond.)51 270\u2013279 (1970).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR110","first-page":"73","volume":"99","author":"W. G. Johanson Jr.","year":"1969","unstructured":"Johanson, W. G., Jr., Nicholson, D. P.: Pulmonary Disease Due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Amer. Rev. resp. Dis.99 73\u201385 (1969).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR111","first-page":"235","volume":"37","author":"H. Kope\u0107","year":"1969","unstructured":"Kope\u0107, H.: Early relapses in inactive pulmonary tuberculosis. Gru\u017alica37 235\u2013242 (1969).","journal-title":"Gru\u017alica"},{"key":"BF02095045_CR112","first-page":"278","volume-title":"Antibiotica et chemotherapia, vol. 1c","author":"J. K. Kraan","year":"1970","unstructured":"Kraan, J. K., Mulder, R. J.: Ethambutol in the treatment of tuberculosis. Antibiotica et chemotherapia, vol. 1c, pp. 278\u2013280. Basel-M\u00fcnchen-New York: Karger 1970."},{"key":"BF02095045_CR113","first-page":"557","volume":"60","author":"J. K. Kraan","year":"1969","unstructured":"\u2014\u2014 \u2014\u2014 van Dijk, B.: Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 557\u2013562 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR114","first-page":"734","volume-title":"R\u00e9sistance et survivance du bacille tuberculeux aux m\u00e9dications antibacillaires","author":"B. Kreis","year":"1966","unstructured":"Kreis, B.: R\u00e9sistance et survivance du bacille tuberculeux aux m\u00e9dications antibacillaires, pp. 734 (siehe S. 672). Paris: Masson et Cie 1966."},{"key":"BF02095045_CR115","first-page":"263","volume-title":"Conditions d'un traitement ambulatoire correct","author":"B. Kreis","year":"1970","unstructured":"\u2014\u2014 Conditions d'un traitement ambulatoire correct. Seizi\u00e8me Congr\u00e8s National de la Tuberculose et des Maladies Respiratoires, Bordeaux 1970, pp. 263, pp. 201\u2013263. Paris: Masson et Cie 1970."},{"key":"BF02095045_CR116","first-page":"59","volume-title":"Antibiotica et Chemotherapia, vol. 16","author":"R. Kropp","year":"1970","unstructured":"Kropp, R., Jungbluth, H., Radenbach, K. L.: Influence of Capreomycin on renal function (preliminary results). Antibiotica et Chemotherapia, vol. 16, pp. 59\u201368. Basel-M\u00fcnchen-New York: Karger 1970."},{"key":"BF02095045_CR117","first-page":"657","volume":"39","author":"M. Kub\u00edn","year":"1968","unstructured":"Kub\u00edn, M., Matu\u0161kov\u00e1, E.: Serological typing of mycobacteria for tracing possible sources of avian mycobacterial infection in man. Bull. W. H. O.39 657\u2013662 (1968).","journal-title":"Bull. W. H. O."},{"key":"BF02095045_CR118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0041-3879(69)90051-8","volume":"50","author":"S. Lal","year":"1969","unstructured":"Lal, S.: Patient's preference of drugs in the treatment of tuberculosis. Tubercle (Lond.)50 269\u2013272 (1969).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR119","unstructured":"Lamy, P., Anthoine, D., Vaillant, G., Monneau, J. P., Georges, J. C., Caubel, F., Lambert, H.: \u00c9tude pr\u00e9liminaire concernant l'action de la rifampicine dans le traitement des tuberculoses pulmonaires chroniques et des rechutes. Int\u00e9r\u00eat de l'association rifampicine-\u00e9thambutol (\u00e0 propos de 28 observations). Rev. Tuberc. (Paris)33 bis, 209\u2013222 (1969)."},{"key":"BF02095045_CR120","first-page":"787","volume":"101","author":"J. K. Lattimer","year":"1970","unstructured":"Lattimer, J. K.: Our presents aspects of Genitourinary tuberculosis. At the 29 VA-AF Conf., Cincinnati, Jan. 1970. Amer. Rev. resp. Dis.101 787\u2013788 (1970).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR121","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0041-3879(69)90058-0","volume":"50","author":"Leading Article","year":"1969","unstructured":"Leading Article: Rifampicin. Tubercle (Lond.)50 318\u2013320 (1969 a).","journal-title":"Rifampicin. Tubercle (Lond.)"},{"key":"BF02095045_CR122","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0041-3879(69)90041-5","volume":"50","author":"Leading Article","year":"1969","unstructured":"\u2014\u2014 The Twentieth International Tuberculosis Conference. Tubercle (Lond.)50 396\u2013400 (1969 b).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR123","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0041-3879(70)90092-9","volume":"51","author":"A. W. Lees","year":"1970","unstructured":"Lees, A. W.: Rifampicin toxicity. Tubercle (Lond.)51 222\u2013223 (1970).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR124","first-page":"849","volume":"66","author":"A. L\u00e9vi-Valensi","year":"1958","unstructured":"L\u00e9vi-Valensi, A., Porot, M., L\u00e9onardon, P., Migu\u00e8res, J., Dalet, R.: Les accidents neuropsychiatriques survenant les tuberculeux trait\u00e9s par la cyclos\u00e9rine. Presse m\u00e9d.66 849\u2013851 (1958).","journal-title":"Presse m\u00e9d."},{"key":"BF02095045_CR125","first-page":"792","volume":"99","author":"B. T. Lim","year":"1969","unstructured":"Lim, B. T., Aquinas, M.: Ethambutol and capreomycin in the re-treatment of advanced pulmonary tuberculosis. Amer. Rev. resp. Dis.99 792\u2013793 (1969).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR126","first-page":"119","volume":"27","author":"M. Lucchesi","year":"1967","unstructured":"Lucchesi, M., Mancini, P., Zubiani, M.: Ricerche sperimentali sull'attivit\u00e0 antimicobatterica della rimfampicina: 3-\/4-metil-1-piperazinil-iminometil-rifamicina SV. Ann. Ist. Forlanini27 119\u2013136 (1967 a).","journal-title":"Ann. Ist. Forlanini"},{"key":"BF02095045_CR127","first-page":"199","volume":"27","author":"M. Lucchesi","year":"1967","unstructured":"\u2014\u2014 Pallotta, G., Rossi, P., Sbampato, M.: L'azione terapeutica della rifampicina, derivato 3-\/4-metil-1-piperazinil-iminometil-rifamicina SV, nella tubercolosi polmonare. Ann. Ist. Forlanini27 199\u2013227 (1967 b).","journal-title":"Ann. Ist. Forlanini"},{"key":"BF02095045_CR128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF02090018","volume":"140","author":"W. Lukas","year":"1969","unstructured":"Lukas, W.: Ursachen und Mi\u00dferfolge in der station\u00e4ren Behandlung der offenen Lungentuberkulose und Wege zu ihrer Beseitigung vom Standpunkt des Kostentr\u00e4gers. Beitr. Klin. Tuberk.140 90\u2013101 (1969).","journal-title":"Beitr. Klin. Tuberk."},{"key":"BF02095045_CR129","first-page":"947","volume":"97","author":"F. M. MacDonald","year":"1968","unstructured":"MacDonald, F. M.: In: The Twenty-seventh Veterans Administration-Armed Forces Pulmonary Disease Conference (report by E. Rothstein). Amer. Rev. resp. Dis.97 947 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR130","first-page":"13","volume":"100","author":"S. K. Malik","year":"1969","unstructured":"Malik, S. K., Martin, C. J.: Tuberculosis, corticosteroid therapy, and pulmonary function. Amer. Rev. resp. Dis.100 13\u201318 (1969).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0041-3879(67)80046-1","volume":"48","author":"Medical Research Council\/Miners Chest Disease Treatment Centre","year":"1967","unstructured":"Medical Research Council\/Miners Chest Disease Treatment Centre: Chemotherapy of pulmonary tuberculosis with pneumoconiosis. Second report to the Medical Research Council from the joint investigators. Tubercle (Lond.)48 1\u201310 (1967).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR132","first-page":"482","volume":"60","author":"G. Meissner","year":"1969","unstructured":"Meissner, G.: Rifampicin in chronic polyresistant cases of pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 482\u2013486 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR133","first-page":"554","volume":"60","author":"G. Meissner","year":"1969","unstructured":"\u2014\u2014 Rifampicin in newly detected, untreated cases of pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 554\u2013556 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR134","first-page":"371","volume":"32","author":"A. Meyer","year":"1968","unstructured":"Meyer, A., Nadjar-Foss\u00e9, G.: The association of isoniazid and thiocarlide DAT in the treatment of pulmonary tuberculosis. Comparison with the association of isoniazid and PAS or B-PAS. Rev. Tuberc. (Paris)32 371\u2013380 (1968).","journal-title":"Rev. Tuberc. (Paris)"},{"key":"BF02095045_CR135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0041-3879(70)90125-X","volume":"51","author":"A. B. Miller","year":"1970","unstructured":"Miller, A. B., Nunn, A. J., Tall, R., Mitchison, D. A.: The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment Services. Tubercle (Lond.)51 24\u201338 (1970).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR136","first-page":"94","volume":"71","author":"R. S. Mitchell","year":"1970","unstructured":"Mitchell, R. S., Lester, W.: Clinical experience with cycloserine in the treatment of tuberculosis. Scand. J. resp. Dis. Suppl.71 94\u2013108 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR137","first-page":"863","volume":"21","author":"V. Monaldi","year":"1966","unstructured":"Monaldi, V.: La rifampicina (rifamicina AMP) nelle prime applicazioni terapeutiche. Arch. Tisiol.21 863\u2013866 (1966).","journal-title":"Arch. Tisiol."},{"key":"BF02095045_CR138","unstructured":"Morr\u00e8re, P., Stain, J. P., Chauvet, M. C., Luce, J. P., Leprovost, J.: Essais cliniques de la rifadine (rifampicine). Rev. Tuberc. (Paris)33 bis, 177\u2013198 (1969)."},{"key":"BF02095045_CR139","first-page":"2025","volume":"113","author":"M. T. Mulder-De Jong","year":"1969","unstructured":"Mulder-De Jong, M. T., Mulder, R. J., van Dijk, B.: Enkele waarnemingen betreffende longaandoeningen met atypische mycobacterien. Ned. T. Geneesk.113 2025\u20132027 (1969).","journal-title":"Ned. T. Geneesk."},{"key":"BF02095045_CR140","unstructured":"Mulder, R. J., Mulder-De Jong, M. T.: Sterilization of tuberculous lesions in man. Co-report. Exc. Medica Int. Congr. Series, 1970, No.205, 360\u2013363."},{"key":"BF02095045_CR141","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0366-0869(56)80085-3","volume":"50","author":"J. M. Murdoch","year":"1956","unstructured":"Murdoch, J. McC., Stewart, S. M.: Viomycin with oxytetracycline in the treatment of pulmonary tuberculosis. Brit. J. Tuberc.50 85\u201392 (1956).","journal-title":"Brit. J. Tuberc."},{"key":"BF02095045_CR142","first-page":"819","volume":"36","author":"H. Nasiadko","year":"1968","unstructured":"Nasiadko, H.: Stabilization of tuberculosis by ambulatory treatment. Gru\u017alica36 819\u2013825 (1968).","journal-title":"Gru\u017alica"},{"key":"BF02095045_CR143","unstructured":"Nitti, V., Ninni, A., Iodice, F.: La mesure de la sensibilit\u00e9 du bacille tuberculeux \u00e0 la rifampicine (Probl\u00e8mes techniques et crit\u00e8res des r\u00e9sistances). Rev. Tuberc. (Paris)33 bis, 25\u201332 (1969)."},{"key":"BF02095045_CR144","first-page":"429","volume":"19","author":"M. Nov\u00e1k","year":"1965","unstructured":"Nov\u00e1k, M., Feitov\u00e1, S., Allegra, L.: Crescita del M. T. su terreno di Loewenstein-Jensen modificato per acidificazione ai fini dell' esecuzione del test di resistenza alla pirazinamide. Riv. sic. Tuberc. Mal. resp.19 429\u2013439 (1965).","journal-title":"Riv. sic. Tuberc. Mal. resp."},{"key":"BF02095045_CR145","first-page":"22","volume":"30","author":"M. Nov\u00e1k","year":"1970","unstructured":"\u2014\u2014 Kr\u00e1tk\u00fd, J., Feitov\u00e1, S.: Assessment of the sensitivity and resistance of M. tuberculosis to pyrazinamide. Stud. pneumol. phtiseol. csl.30 22\u201328 (1970).","journal-title":"Stud. pneumol. phtiseol. csl."},{"key":"BF02095045_CR146","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0041-3879(65)80061-7","volume":"46","author":"M. Olejn\u00ed\u010dek","year":"1965","unstructured":"Olejn\u00ed\u010dek, M., Weberov\u00e1, M., Nov\u00e1k, M., Jan\u010d\u00edk, E.: A controlled trial of isoniazid and 4\u20134 diisoamyloxythiosemicarbanilide compared with isoniazid and PAS and isoniazid, streptomycin and PAS. Tubercle (Lond.)46 188\u2013192 (1965).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR147","first-page":"258","volume":"101","author":"G. D. Onsted","year":"1970","unstructured":"Onsted, G. D., Sbarbaro, J. A., Rotenberg, L.: Posthospital chemotherapy of the unreliable patient. Amer. Rev. resp. Dis.101 258\u2013264 (1970).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR148","first-page":"68","volume":"72","author":"L. Perret","year":"1970","unstructured":"Perret, L.: Pulmonary tuberculosis and diabetes mellitus. Scand. J. resp. Dis. Suppl.72 68\u201371 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR149","first-page":"513","volume":"60","author":"G. Pickroth","year":"1969","unstructured":"Pickroth, G., Anschel, R., Kalich, R., Kandt, D.: Rifampicin in the treatment of chronic pulmonary tuberculosis. Investigations on clinical activity and side effects. Acta tuberc. pneumol. belg.60 513\u2013518 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR150","unstructured":"Pines, A.: Treatment of drug-resistant tuberculosis and preliminary results obtained with rimactane. In: A Symposium on Rimactane. Basle, 1st Nov. 1968, pp. 96\u201399. Ciba Basel."},{"key":"BF02095045_CR151","first-page":"783","volume":"69","author":"V. A. Place","year":"1969","unstructured":"Place, V. A., Pyle, M. M., Huerga, J. de la: Ethambutol in tuberculous meningitis. Amer. Rev. resp. Dis.69 783\u2013785 (1969).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR152","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.1.5636.82","volume":"1","author":"G. Poole","year":"1969","unstructured":"Poole, G., Stradling, P.: Intermittent chemotherapy for tuberculosis in an urban community. Brit. med. J.1 82\u201384 (1969).","journal-title":"Brit. med. J."},{"key":"BF02095045_CR153","first-page":"30","volume":"50","author":"M. M. Pyle","year":"1969","unstructured":"Pyle, M. M.: Clinical applications of ethambutol. Tubercle (Lond.) Suppl.50 30\u201332 (1969).","journal-title":"Tubercle (Lond.) Suppl."},{"key":"BF02095045_CR154","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF02144560","volume":"125","author":"K. L. Radenbach","year":"1962","unstructured":"Radenbach, K. L., Hauck, S., Rossberg, G.: M\u00f6glichkeiten und Grenzen der Tuberkulose-Behandlung mit Kanamycin. Beitr. Klin. Tuberk.125 78\u201396 (1962).","journal-title":"Beitr. Klin. Tuberk."},{"key":"BF02095045_CR155","first-page":"43","volume":"69","author":"K. L. Radenbach","year":"1969","unstructured":"\u2014\u2014 Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin. Scand. J. resp. Dis. Suppl.69 43\u201353 (1969 a).","journal-title":"Berlin. Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR156","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02090024","volume":"140","author":"K. L. Radenbach","year":"1969","unstructured":"\u2014\u2014 Vermeidbare Fehler der antituberkul\u00f6sen Chemotherapie. Beitr. Klin. Tuberk.140 128\u2013141 (1969 b).","journal-title":"Beitr. Klin. Tuberk."},{"key":"BF02095045_CR157","first-page":"151","volume":"1","author":"K. L. Radenbach","year":"1970","unstructured":"\u2014\u2014 Konservative Behandlung der Urogenitaltuberkulose in Klinik und Praxis. Act. Urol.1 151\u2013163 (1970).","journal-title":"Act. Urol."},{"key":"BF02095045_CR158","first-page":"783","volume":"101","author":"J. Raleigh","year":"1970","unstructured":"Raleigh, J.: In: Rothstein, E., The Twenty Ninth Veterans Administration \u2014 Armed Forces Pulmonary Diseases Research Conference. Amer. Rev. resp. Dis.101 783\u2013801 (1970).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR159","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0041-3879(69)90018-X","volume":"50","author":"C. V. Ramakrishnan","year":"1969","unstructured":"Ramakrishnan, C. V., Devadatta, S., Evans, C., Fox, W., Menon, N. K., Nazareth, O., Rahakrishna, S., Sambamoorthy, S., Stott, H., Tripathy, S. P., Velu, S.: A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice weekly isoniazid plus streptomycin or daily isoniazid plus PAS. Tubercle (Lond.)50 115\u2013124 (1969).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR160","first-page":"775","volume":"39","author":"C. V. Ramakrishnan","year":"1968","unstructured":"\u2014\u2014 Janardhanam, B., Krishnamurty, D. V., Stoot, H., Subbamal, S., Tripathy, S. P.: Toxicity of pyrazinamide, administered one weekly in high dosage. In: Tuberculous Patients. Bull. W.H.O.39 775\u2013779 (1968).","journal-title":"Tuberculous Patients. Bull. W.H.O."},{"key":"BF02095045_CR161","unstructured":"Regli, J.: Erfahrungen mit Rimactan in der station\u00e4ren Tuberkulosebehandlung. In: A Symposium on Rimactane. Basle, 1st Nov. 1968, pp. 91\u201395. Ciba, Basel."},{"key":"BF02095045_CR162","first-page":"72","volume":"72","author":"U. K. Repo","year":"1970","unstructured":"Repo, U. K., Hellstr\u00f6m, P.-E.: Capreomycin and ethambutol in pulmonary tuberculosis. A preliminary report. Scand. J. resp. Dis. Suppl.72 72\u201375 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR163","unstructured":"Riess, W.: The optimum dosage schedule for rimactane. A Symposium on rimactane, Ciba. Basel, 1st Nov. 1968, pp. 36\u201342."},{"key":"BF02095045_CR164","first-page":"11","volume":"74","author":"N. Riska","year":"1970","unstructured":"Riska, N., Rinne, T.: Rifampicin in the treatment of tuberculosis. Scand. J. resp. Dis. Suppl.74 11 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR165","first-page":"220","volume":"28","author":"N. Rist","year":"1958","unstructured":"Rist, N.: Le thioamide de l'acide alpha-\u00e9thylisonicotinique (1314 TH). Bull. Un. int. Tuberc.28 220\u2013228 (1958).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR166","unstructured":"-- La r\u00e9sistance du bacille tuberculeux \u00e0 la rifampicine. Rev. Tuberc. (Paris)33 bis, 33\u201337 (1969)."},{"key":"BF02095045_CR167","first-page":"27","volume":"13","author":"E. H. Robitzek","year":"1952","unstructured":"Robitzek, E. H., Selikoff, F. J., Ornstein, G. G.: Chemotherapy of human tuberculosis with hydrazine derivates of isonicotinic acid. Quart. Bull. Sea View Hosp.13 27\u201351 (1952).","journal-title":"Quart. Bull. Sea View Hosp."},{"key":"BF02095045_CR168","first-page":"783","volume":"101","author":"E. Rothstein","year":"1970","unstructured":"Rothstein, E.: The Twenty-ninth Veterans-Administration Pulmonary Disease Research Conference (Cincinnati, Ohio, Jan. 26 to 28, 1970). Amer. Rev. resp. Dis.101 783\u2013801 (1970).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR169","first-page":"895","volume":"97","author":"J. A. Sbarbaro","year":"1968","unstructured":"Sbarbaro, J. A., Johnson, S.: Tuberculous chemotherapy for recalcitrant outpatients administered directly twice weekly. Amer. Rev. resp. Dis.97 895\u2013903 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0041-3879(68)80003-0","volume":"49","author":"M. E. Schonell","year":"1968","unstructured":"Schonell, M. E., Crofton, J. W., Stuart, A. E., Wallace, A.: Disseminated infection with mycobacterium avium: Part I \u2014 Clinical features, treatment and pathology. Tubercle (Lond.)49 12\u201330 (1968).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR171","first-page":"437","volume":"60","author":"I. Sch\u00fctz","year":"1969","unstructured":"Sch\u00fctz, I.: A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. (Preliminary results of the third cooperative study of the WATL). Acta tuberc. pneumol. belg.60 437\u2013441 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR172","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF02090049","volume":"140","author":"I. Sch\u00fctz","year":"1969","unstructured":"\u2014\u2014 Bartmann, K., Radenbach, K. L., Siegler, W.: Vergleich der Vertr\u00e4glichkeit von Prothionamid und Ethionamid im Doppelblindversuch. Beitr. Klin. Tuberk.140 296\u2013303 (1969).","journal-title":"Beitr. Klin. Tuberk."},{"key":"BF02095045_CR173","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000386803","volume":"16","author":"I. Sch\u00fctz","year":"1970","unstructured":"\u2014\u2014 Radenbach, K. L., Bartmann, K.: The combination of ethambutol, capreomycin and a third drug in chronic pulmonary tuberculosis with bacterial polyresistance. Antibiotica et chemotherapia, vol. 16, pp. 43\u201358. Basel-M\u00fcnchen-New York: Karger 1970.","journal-title":"Antibiotica et chemotherapia"},{"key":"BF02095045_CR174","first-page":"322","volume":"30","author":"W. S. Schwartz","year":"1960","unstructured":"Schwartz, W. S., Tucker, W. S.: Kanamycin in the treatment of pulmonary tuberculosis. Bull. Un. int. Tuberc.30 322\u2013327 (1960).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR175","first-page":"76","volume":"72","author":"T. L. Sellergren","year":"1970","unstructured":"Sellergren, T. L.: Relapse of tuberculosis in relation to previous treatment. Scand. J. resp. Dis. Suppl.72 76\u201382 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR176","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0041-3879(69)90011-7","volume":"50","author":"J. B. Selkon","year":"1969","unstructured":"Selkon, J. B.: \u201cAtypical\u201d mycobacteria: A review. Tubercle (Lond.) Suppl.50 70\u201378 (1969).","journal-title":"Tubercle (Lond.) Suppl."},{"key":"BF02095045_CR177","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0041-3879(70)90091-7","volume":"51","author":"A. R. Somner","year":"1970","unstructured":"Somner, A. R.: Drug resistant tuberculosis treated with ethambutol and rifampicin in North East England. Tubercle (Lond.)51 222 (1970).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR178","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0041-3879(62)80003-8","volume":"43","author":"A. R. Somner","year":"1962","unstructured":"\u2014\u2014 Brace, A.: Ethionamide, pyrazinamide, and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis. Tubercle (Lond.)43 345\u2013360 (1962).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR179","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0366-0869(57)80031-8","volume":"51","author":"S. M. Stewart","year":"1957","unstructured":"Stewart, S. M., Murdoch, J. McC., Crofton, J. W., Hay, D.: Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid. Brit. J. Tuberc.51 158\u2013167 (1957).","journal-title":"Brit. J. Tuberc."},{"key":"BF02095045_CR180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0041-3879(70)90127-3","volume":"51","author":"P. Stradling","year":"1970","unstructured":"Stradling, P., Poole, G. W.: Twice weekly streptomycin plus isoniazid for tuberculosis. Tubercle (Lond.)51 44\u201347 (1970).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR181","first-page":"83","volume":"72","author":"E. Strandgaard","year":"1970","unstructured":"Strandgaard, E.: Pulmonary tuberculosis in elderly and aged patients. Scand. J. resp. Dis. Suppl.72 83 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR182","unstructured":"Symposium sur les thioamides \u2014 leur place actuelle dans la lutte contre la tuberculose. Symposium tenu \u00e0 l'occasion de la XXe Conf\u00e9rence de l'Union Internationale contre la Tuberculose \u00e0 New York, le 3 Septembre 1969 (Mod\u00e9rateur E. Jan\u010d\u00edk, R\u00e9daction E. Jan\u010d\u00edk, J. K. Kraan). Paris: (sous presse, Paris)."},{"key":"BF02095045_CR183","first-page":"729","volume":"32","author":"A. Tacquet","year":"1968","unstructured":"Tacquet, A., Devulder, B.: Ethambutol in the treatment of pulmonary tuberculosis. Rev. Tuberc. (Paris)32 729\u2013748 (1968).","journal-title":"Rev. Tuberc. (Paris)"},{"key":"BF02095045_CR184","unstructured":"-- -- Martin, J. C., Daniel, H. Mme, Le Bouffant, L.: Activit\u00e9 antimycobact\u00e9rienne de la rifampicine. Rev. Tuberc. (Paris)33 bis, 61\u201380 (1969)."},{"key":"BF02095045_CR185","unstructured":"-- Savinel, E., Devulder, B., Duthot, A.: La rifampicine dans le traitement de la tuberculose pulmonaire (note pr\u00e9liminaire). Rev. Tuberc. (Paris)33 bis, 135\u2013146 (1969)."},{"key":"BF02095045_CR186","first-page":"8","volume":"74","author":"A. Tala","year":"1970","unstructured":"Tala, A.: Treatment of pulmonary diseases of elderly patients in hospital. Scand. J. resp. Dis. Suppl.74 8 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR187","first-page":"93","volume":"72","author":"P. Tani","year":"1970","unstructured":"Tani, P.: Medical and social aspects of chronic pulmonary tuberculosis in Finland. Scand. J. resp. Dis. Suppl.72 93\u2013105 (1970).","journal-title":"Scand. J. resp. Dis. Suppl."},{"key":"BF02095045_CR188","first-page":"478","volume":"60","author":"J. Tou\u0161ek","year":"1969","unstructured":"Tou\u0161ek, J.: First experience with rifampicin in retreatment of resistant cases. Acta tuberc. pneumol. belg.60 478\u2013481 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR189","first-page":"398","volume":"29","author":"J. Tou\u0161ek","year":"1969","unstructured":"\u2014\u2014 Zelenka, M., Jan\u010d\u00edk, E.: Therapeutic possibilities in patients with pulmonary tuberculosis excreting tubercle bacilli resistant to INH, SM and PAS. Rozhl. Tuberk.29 398\u2013413 (1969).","journal-title":"Rozhl. Tuberk."},{"key":"BF02095045_CR190","first-page":"13","volume":"30","author":"J. Tou\u0161ek","year":"1970","unstructured":"\u2014\u2014 Z\u00edtkov\u00e1, L., \u010cel\u00edkovsk\u00e1, M., \u0160tastn\u00e1, J.: Prothionamide in clinical application. Stud. pneumol. phtiseol. csl.30 13\u201321 (1970).","journal-title":"Stud. pneumol. phtiseol. csl."},{"key":"BF02095045_CR191","first-page":"356","volume":"60","author":"L. Trnka","year":"1969","unstructured":"Trnka, L.: Mechanism of rifampicin action on mycobacterial cells. Considerations to the potentiation problem of antimycobacterial treatment. Acta tuberc. pneumol. belg.60 356\u2013365 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR192","first-page":"51","volume":"21","author":"Tuberculosis Chemotherapy Centre, Madras","year":"1959","unstructured":"Tuberculosis Chemotherapy Centre, Madras: A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Bull. W. H. O.21 51\u2013144 (1959).","journal-title":"Bull. W. H. O."},{"key":"BF02095045_CR193","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0041-3879(59)80104-5","volume":"40","author":"Tuberculosis Chemotherapy Centre, Madras","year":"1959","unstructured":"Tuberculosis Chemotherapy Centre, Madras: A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Tubercle (Lond.)40 468\u2013478 (1959).","journal-title":"Tubercle (Lond.)"},{"issue":"1","key":"BF02095045_CR194","first-page":"23","volume":"II","author":"Tuberculosis Chemotherapy Centre, Madras","year":"1959","unstructured":"\u2014\u2014 Bull. W. H. O., Lancet,1959 II 1; 23, 535\u2013585 (1960);31, 247 (1964);34, 483 (1966).","journal-title":"Bull. W. H. O., Lancet"},{"key":"BF02095045_CR195","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bmj.2.5054.1131","volume":"2","author":"Tuberculosis Society of Scotland","year":"1957","unstructured":"Tuberculosis Society of Scotland: Prednison in the treatment of tuberculosis controlled trial. Brit. med. J.2 1131 (1957).","journal-title":"Brit. med. J."},{"key":"BF02095045_CR196","first-page":"812","volume":"70","author":"W. B. Tucker","year":"1954","unstructured":"Tucker, W. B.: Re-treatment of advanced pulmonary tuberculosis with viomycin. Amer. Rev. Tuberc.70 812\u2013840 (1954).","journal-title":"Amer. Rev. Tuberc."},{"key":"BF02095045_CR197","first-page":"1","volume":"10","author":"W. B. Tucker","year":"1960","unstructured":"\u2014\u2014 The evolution of the cooperative studies in the chemotherapy of tuberculosis of the Veterans Administration and Armed Forces of the U.S.A. Tuberc. Res.10 1\u201368 (1960).","journal-title":"Tuberc. Res."},{"key":"BF02095045_CR198","first-page":"549","volume":"29","author":"W. B. Tucker","year":"1959","unstructured":"\u2014\u2014 Matthews, J. H.: Pyrazinamide used with INH in the treatment of pulmonary tuberculosis. Bull. Un. int. Tuberc.29 549\u2013555 (1959).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR199","first-page":"598","volume":"81","author":"United States Public Health Service \u2014 Tuberculosis Study Group","year":"1960","unstructured":"United States Public Health Service \u2014 Tuberculosis Study Group: Preliminary observations from a controlled trial of prednisone in the treatment of tuberculosis. Amer. Rev. resp. Dis.81 598\u2013600 (1960).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR200","first-page":"825","volume":"98","author":"United States Public Health Service Tuberculosis Therapy Trial","year":"1968","unstructured":"United States Public Health Service Tuberculosis Therapy Trial: Ethambutol in re-treatment of pulmonary tuberculosis. Amer. Rev. resp. Dis.98 825\u2013836 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR201","first-page":"783","volume":"101","author":"A. Vall-Spinosa","year":"1970","unstructured":"Vall-Spinosa, A., Lester, W., et al.: In: Rothstein, E.: The twenty ninth Veterans Administration \u2014 Armed Forces Pulmonary Diseases Research Conference. Amer. Rev. resp. Dis.101 783\u2013801 (1970).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR202","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0041-3879(68)80022-4","volume":"19","author":"S. Velu","year":"1968","unstructured":"Velu, S., Sambamoorthy, S.: A Note on the Relapse rate over a 4-year period in patients with quiescent pulmonary tuberculosis following treatment with reserve regimens. Tubercle (Lond.)19 410\u2013412 (1968).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR203","first-page":"533","volume":"23","author":"P. V\u00e9ran","year":"1959","unstructured":"V\u00e9ran, P., Moigneteau, C., Trichereau, R., Rist, N.: Le 1314 Th ou thioamide de l'acide alpha-\u00e9thyl-isonicotinique dans le traitement de la tuberculose cavitaire. Rev. Tuberc. (Paris)23 533\u2013569 (1959).","journal-title":"Rev. Tuberc. (Paris)"},{"key":"BF02095045_CR204","first-page":"288","volume":"60","author":"L. Verbist","year":"1969","unstructured":"Verbist, L.: Rifampicin blood levels in man. Acta tuberc. pneumol. belg.60 288\u2013298 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR205","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0041-3879(69)90076-2","volume":"50","author":"L. Verbist","year":"1969","unstructured":"\u2014\u2014 Experimental study of the activity of Rifampicin in vitro and in vivo. Tubercle (Lond.)50 327\u2013328 (1969).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR206","first-page":"923","volume":"68","author":"L. Verbist","year":"1968","unstructured":"\u2014\u2014 Gyselen, A.: Antituberculous activity of Rifampicin in vitro and in vivo and the concentrations atteined in human blood. Amer. Rev. resp. Dis.68 923\u2013932 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR207","first-page":"448","volume":"60","author":"C. Virchow","year":"1969","unstructured":"Virchow, Chr., Flemming, J.: Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 448\u2013470 (1969).","journal-title":"Acta tuberc. pneumol. belg."},{"key":"BF02095045_CR208","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02091505","volume":"139","author":"W. A. T. L.","year":"1969","unstructured":"W. A. T. L.: Kooperative kontrollierte Pr\u00fcfung von Thiocarlid (DATC), PAS und Bettruhe in kurzfristiger Monotherapie bei kavern\u00f6ser vorbehandelter Lungentuberkulose. Beitr. Klin. Tuberk.139 115\u2013139 (1969).","journal-title":"Beitr. Klin. Tuberk."},{"key":"BF02095045_CR209","first-page":"283","volume":"33","author":"G. Weill","year":"1969","unstructured":"Weill, G., Varin, E., Stoeckel, Ch.: La rifampicine dans le traitement de la tuberculose pulmonaire. Rev. Tuberc. (Paris)33 283\u2013290 (1969).","journal-title":"Rev. Tuberc. (Paris)"},{"key":"BF02095045_CR210","first-page":"523","volume":"65","author":"R. L. Yeager","year":"1952","unstructured":"Yeager, R. L., Munroe, W. C. C., Dessau, F. I.: Pyrazinamide (Aldinamide) in the treatment of pulmonary tuberculosis. Amer. Rev. Tuberc.65 523\u2013534 (1952).","journal-title":"Amer. Rev. Tuberc."},{"key":"BF02095045_CR211","first-page":"136","volume":"97","author":"M. H. Zaki","year":"1968","unstructured":"Zaki, M. H., Edelstein, S., Josephson, R. A., Weisberg, S. R.: Regularity of drug administration among hospitalized and ambulatory tuberculous patients. Amer. Rev. resp. Dis.97 136\u2013139 (1968).","journal-title":"Amer. Rev. resp. Dis."},{"key":"BF02095045_CR212","first-page":"500","volume":"16","author":"M. Zelenka","year":"1962","unstructured":"Zelenka, M., Jan\u010d\u00edk, E.: Viomycinsulfat und Viothenat \u2014 toxische und Nebenerscheinungen bei Behandlung von chronischen Tuberkulosef\u00e4llen. Tuberk.-Arzt16 500\u2013505 (1962).","journal-title":"Tuberk.-Arzt"},{"key":"BF02095045_CR213","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02144617","volume":"125","author":"M. Zierski","year":"1962","unstructured":"Zierski, M.: Die Behandlung der Lungentuberkulose bei resistenten Tuberkelbakterien. Beitr. Klin. Tuberk.125 15\u201321 (1962).","journal-title":"Beitr. Klin. Tuberk."},{"key":"BF02095045_CR214","first-page":"194","volume":"41","author":"M. Zierski","year":"1968","unstructured":"\u2014\u2014 The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics. Bull. Un. int. Tuberc.41 194\u2013200 (1968).","journal-title":"Bull. Un. int. Tuberc."},{"key":"BF02095045_CR215","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0041-3879(70)90069-3","volume":"51","author":"M. Zierski","year":"1970","unstructured":"\u2014\u2014 Zachara, A.: Late results in re-treatment of patients with pulmonary tuberculosis. Tubercle (Lond.)51 172\u2013177 (1970).","journal-title":"Tubercle (Lond.)"},{"key":"BF02095045_CR216","first-page":"809","volume":"36","author":"M. Zierski","year":"1968","unstructured":"\u2014\u2014 \u2014\u2014 Wo\u017aniak, S.: Results of treatment with triple-drug regimes of reserve drugs in cavitary pulmonary tuberculosis. A study under the auspices of the International Union against Tuberculosis. Gru\u017alica36 809\u2013818 (1968) (zit. Amer. Rev. resp. Dis.99, 638\u2013639, 1969).","journal-title":"Gru\u017alica"}],"container-title":["Pneumonologie Pneumonology"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02095045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02095045\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02095045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T10:22:30Z","timestamp":1557829350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02095045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1971,12]]},"references-count":216,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1971,12]]}},"alternative-id":["BF02095045"],"URL":"https:\/\/doi.org\/10.1007\/bf02095045","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[1971,12]]}}}